Cotización PepGen - PEPG

Su centro para precios en tiempo real, ideas y debates en vivo

Premium

Último Precio

4.51

Postura de Compra

4.19

Postura de Venta

4.71

Volume Operado de la Acción

0.00 Rango del Día 0.00

2.90 Rango de 52 semanas 19.298

Capitalización de Mercado [m]

147.007M

Precio Anterior

4.51

Precio de Apertura

Hora

Última hora de negociación

Volumen financiero

Precio Promedio Ponderado

Volumen promedio (3 m)

143,330

Acciones en circulación

32,595,737

Rendimiento del Dividendo

Ratio Precio/Utilidad

-1.87

Beneficio por acción (BPA)

-2.41

turnover

Beneficio neto

-78.63M

PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases. PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases.

Sector

Pharmaceutical Preparations

Industria

Pharmaceutical Preparations

Sitio web

pepgen.com

Sede

Wilmington, Delaware, USA

Fundado

PepGen Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker PEPG. The last closing price for PepGen was US$4.51. Over the last year, PepGen shares have traded in a share price range of US$ 2.90 to US$ 19.298.

PepGen currently has 32,595,737 shares in issue. The market capitalisation of PepGen is US$147.01 million. PepGen has a price to earnings ratio (PE ratio) of -1.87.

Form 8-K - Current report

PepGen Announces Clinical Hold in the U.S. on IND Application to Initiate CONNECT2-EDO51 Phase 2 Study of PGN-EDO51 for Duchenne Muscular Dystrophy

-Company continues to advance PGN-EDO51 in CONNECT1-EDO51, with the 10 mg/kg cohort now fully enrolled- PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next...

PepGen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Senior Vice President, Clinical Development

PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular...

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	-0.9127	-16.8310988991	5.4227	5.72	2.9	460713	4.7138528	CS
4	0.4987	12.4323785307	4.0113	6.85	2.9	221253	5.06499377	CS
12	-4.36	-49.1544532131	8.87	9.935	2.9	143330	5.83116421	CS
26	-12.49	-73.4705882353	17	19.298	2.9	155939	9.46590959	CS
52	-2.11	-31.8731117825	6.62	19.298	2.9	127445	10.8028681	CS
156	-11.09	-71.0897435897	15.6	20	2.9	112820	10.85310861	CS
260	-11.09	-71.0897435897	15.6	20	2.9	112820	10.85310861	CS

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
AALAmerican Airlines Group Inc	US$ 16.52 (0.00%)	0
AAGRAfrican Agriculture Holdings Inc	US$ 0.1326 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	US$ 71.69 (0.00%)	0
AADIAadi Bioscience Inc	US$ 2.38 (0.00%)	0
AACGATA Creativity Global	US$ 0.8991 (0.00%)	0
AALAmerican Airlines Group Inc	US$ 16.52 (0.00%)	0
AAGRAfrican Agriculture Holdings Inc	US$ 0.1326 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	US$ 71.69 (0.00%)	0
AADIAadi Bioscience Inc	US$ 2.38 (0.00%)	0
AACGATA Creativity Global	US$ 0.8991 (0.00%)	0
AALAmerican Airlines Group Inc	US$ 16.52 (0.00%)	0
AAGRAfrican Agriculture Holdings Inc	US$ 0.1326 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	US$ 71.69 (0.00%)	0
AADIAadi Bioscience Inc	US$ 2.38 (0.00%)	0
AACGATA Creativity Global	US$ 0.8991 (0.00%)	0